We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
StoneX
SNEX
$7.94B
| $6.78M | ﹤0.01% |
703,222
-8,312
| -1% | -$68.8K |
|
|
TPTX
1827
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.77M | ﹤0.01% |
108,643
+92,035
| +554% | +$4.38M |
|
|
AVNS
1828
DELISTED
Avanos Medical
AVNS
| $6.76M | ﹤0.01% |
200,665
+108
| +0.1% | +$3.91K |
|
|
CBPX
1829
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $6.73M | ﹤0.01% |
184,690
-257,593
| -58% | -$8.47M |
|
1830
HNI Corp
HNI
$3.59B
| $6.73M | ﹤0.01% |
179,626
-3,580
| -2% | -$137K |
|
1831
Chefs' Warehouse
CHEF
$4.5B
| $6.73M | ﹤0.01% |
176,500
-1,731
| -1% | -$63K |
|
|
SAFE
1832
Safehold
SAFE
$1.15B
| $6.7M | ﹤0.01% |
94,905
-594
| -0.6% | -$37.6K |
|
1833
Fate Therapeutics
FATE
$326M
| $6.7M | ﹤0.01% |
342,405
+28,253
| +9% | +$449K |
|
|
PRSU
1834
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $6.68M | ﹤0.01% |
98,964
-91,305
| -48% | -$5.92M |
|
1835
Autohome
ATHM
$2.62B
| $6.66M | ﹤0.01% |
83,233
+2,500
| +3% | +$195K |
|
1836
CNX Resources
CNX
$5.2B
| $6.63M | ﹤0.01% |
749,470
-10,506
| -1% | -$82K |
|
|
KDMN
1837
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.62M | ﹤0.01% |
1,460,704
+1,018,352
| +230% | +$3.73M |
|
1838
Canadian Pacific Kansas City
CP
$80.5B
| $6.61M | ﹤0.01% |
+129,675
| New | +$6.08M |
|
1839
Horizon Bancorp
HBNC
$1.04B
| $6.6M | ﹤0.01% |
347,308
+36,108
| +12% | +$662K |
|
1840
Stoneridge
SRI
$213M
| $6.6M | ﹤0.01% |
225,043
-29,232
| -11% | -$900K |
|
1841
Icon
ICLR
$12.7B
| $6.59M | ﹤0.01% |
+38,268
| New | +$5.9M |
|
1842
Winnebago Industries
WGO
$909M
| $6.56M | ﹤0.01% |
123,779
-5,076
| -4% | -$237K |
|
1843
Brinker International
EAT
$9.66B
| $6.55M | ﹤0.01% |
156,047
-29,440
| -16% | -$1.27M |
|
1844
Cerence
CRNC
$413M
| $6.5M | ﹤0.01% |
+287,370
| New | +$4.71M |
|
1845
Element Solutions
ESI
$9.23B
| $6.49M | ﹤0.01% |
556,007
+42,281
| +8% | +$467K |
|
|
SGMO
1846
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $6.47M | ﹤0.01% |
772,848
+32,337
| +4% | +$297K |
|
1847
Enerpac Tool Group
EPAC
$1.93B
| $6.45M | ﹤0.01% |
247,950
-6,888
| -3% | -$168K |
|
|
RARX
1848
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $6.45M | ﹤0.01% |
137,505
-22,778
| -14% | -$1.01M |
|
1849
Acushnet Holdings
GOLF
$5.45B
| $6.44M | ﹤0.01% |
198,075
+70,564
| +55% | +$2.1M |
|
1850
iShares MSCI South Korea ETF
EWY
$25.7B
| $6.44M | ﹤0.01% |
103,488
+45,102
| +77% | +$2.68M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.